Скачать или смотреть Mammograms Aren’t Enough — Here’s a Better Way to Detect Breast Cancer Early

#breastcancer #cancerscreening #precisionmedicine #oncology #earlydetection

This video highlights the importance of *breast screening* and *early detection**, especially for women with **dense breast tissue**. Using **ultrasound breast* can be extremely valuable, along with making sure to utilize a *mammogram machine* for **cancer screening**, because **early detection saves lives**.

Everyone’s heard of mammograms — but few know about QT Breast Ultrasound, a powerful tool that can detect breast cancer even in dense tissue.

I’m Dr. Dino Prado from Envita Medical Centers, and this technology allows us to see cysts, lesions, and early changes that mammograms often miss. When combined with *baseline imaging* and **early multi-cancer detection testing**, we can identify cancer before it grows — usually while it’s still very small.

👉 Watch the full episode here:    • Why Your Breast Cancer Screening May Not B...  
👉 Learn more at https://www.envita.com

🧬 About Dr. Dino Prato and Envita Medical Centers
My life's work at Envita Medical Centers has been a mission to help patients find hope when they've run out of options. As a pioneer in precision personalized medicine, I founded Envita Medical Centers to offer next-level care. We use state-of-the-art testing and treatments that are not only data-driven but also precisely targeted to each individual.

By the grace of God, we've been able to help many families. Our approach isn't about treating a disease; it's about treating a unique person and providing a custom blueprint for healing. We believe every life is precious and unrepeatable, and we approach each patient with the love and dignity they deserve. The message we give them is one of life and hope.

📍 Envita Medical Centers – At Envita Medical Centers in Scottsdale, AZ, we believe in a radical, loving approach to patient care. Our unique campus is home to a dedicated team of over 400 professionals, including doctors (MD, DO, NMD), pharmacists, nurses, and researchers, all working together in a seamless ecosystem.

What truly sets us apart is our commitment to precision personalized care. Our physicians undergo over 2,000 hours of specialized training in molecular targeting, with a mandatory one-year training period regardless of their previous background. This ensures every member of our team is an expert in the highly specialized, data-driven approach we use.

We help patients outperform expectations by providing a custom, targeted plan from initial testing to the delivery of care.

To learn more, visit: https://www.envita.com

📞 Ready to begin your healing journey?
Speak with a patient care coordinator today: 866-830-4576

🔗 Explore More Episodes
Subscribe for more interviews, case studies, and expert breakdowns from the frontlines of precision medicine.

📩 For press, media, or guest inquiries: [email protected]

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.
You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperin...